The SLICC/ACR damage index: Progress report and experience in the field

Lupus

Volumn 8, Issue 8, 1999, Pages 632-637

  Gladman, D D ^a,b   Urowitz, Murray B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Damage index; Outcome; Prognosis; SLE; SLICC ACR

Indexed keywords

CLINICAL RESEARCH; DISEASE ACTIVITY; DISEASE COURSE; EXPERIENCE; HUMAN; LONGITUDINAL STUDY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

HEALTH STATUS INDICATORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 0032708041     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399680411335     Document Type: Review

References (31)

1. Gladman DD, Urowitz MB. Prognostic subsets and mortality in systemic lupus erythematosus. Dubois' Lupus Erythematosus; 5th edition; 1997. Wallace D, Hahn B (eds). Williams & Wilkins: Baltimore, pp. 1213-1327.
2. Urowitz MB, Abu-Shakra M, Gladman DD et al. Improved survival in SLE. J Rheumatol 1997; 24: 1061-1065.
3. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheum 1987; 14 (Suppl 13): s223-s226.
4. Bombardier C, Gladman DD, Urowitz MB et al. The development and validaton of the SLE Disease Activity Index (SLEDAI). Arthritis Rheum 1992; 35: 630-640.
5. Urowitz MB. Late mortality and morbidity. Proceedings of the 2nd International Conference on Systemic Lupus Erythematosus. Professional Post-graduate Services International, Singapore. 1989; 190-193.
6. Gladman DD, Ginzler E. Goldsmith C et al. Workshop report-Systemic Lupus International Collaborative Clinics (SLICC): development of a damage index in SLE. J Rheumatol 1992; 19: 1820-1821.
7. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 1996; 39: 363-369.
8. Gladman DD, Goldsmith CH, Urowitz MB et al. Cross-cultural validation of three disease activity indices in systemic lupus erythematosus (SLE). J Rheumatol 1992; 19: 608-611.
9. Gladman D, Urowitz MB, Goldsmith C et al. Assessment of the reliability of the SLICC/ACR damage index for SLE. Arthritis Rheum 1997; 40: 809-813.
10. Gorgos L, Goldman D, Petri M. The ACR/SLICC damage index in systemic lupus erythematosus (SLE). Arthritis Rheum 1993; 36 (Suppl 9):S68 (abstract).
11. Fortin PR, Fraenkel L, Danoff D, Abrahamowicz M. Clinical predictors of function in systemic lupus erythematosus. Arthritis Rheum 1994; 37 (Suppl 9):S326 (abstract).
12. Gladman D, Urowitz M, Ong A et al. Lack of correlation among 3 outcome measures in SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 1996; 14: 305-308.
13. Gladman DD, Goldsmith C, Urowitz M et al. Systemic lupus international collaborating clinics. SLICC damage index: international comparison. J Rheumatol in press.
14. Gladman DD, Goldsmith C, Urowitz M et al. Derivation of a weighting scale for the SLICC/ACR damage index: preliminary results. Arthritis Rheum 1994; 37 (Suppl 9:S326) (abstract).
15. Gladman DD, Goldsmith CH, Urowitz MB et al. A weighted scale for the SLICC/ACR damage index is not superior to the original damage index, submitted for publication.
16. Stoll T, Seifert B, Isenberg DA. SLICC/ACR damage index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996; 35: 248-254.
17. Nossent JC SLICC/ACR damage index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, steroid therapy, and prognosis. J Rheumatol 1998; 25: 654-659.
18. Fortin PR, Feland D, Clarke AE et al. Activity and damage predict later flares in lupus. Arthritis Rheum 1997; 40 (Suppl 9):S207
19. Bastian HM, Mickail I, Straaton KV et al. Factors associated with early death in African-American and Hispanic patients with SLE. Arthritis Rheum 1997; 40 (Suppl 9):S160.
20. Bootsma H, Derksen RHWM, Jaegers SMHJ et al. Usefulness of the SLICC/ACR damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40 (Suppl 9):S160 (abstract).
21. Zonana-Nacach A, Camargo-Coronel A, Yanez P et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998; 7: 119-123.
22. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol 1998; 27: 98-105.
23. Karlson EW, Daltroy LH, Lew RA et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 47-56.
24. Gladman D, Urowitz M, Gough J, MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997; 24: 2145-2149.
25. Bruce IN, Mak V, Hallett DC et al. Factors associated with fatigue in patients, with systemic lupus erythematosus. Ann Rheum Dis 1999; 58. 379-381.
26. Hanly JG. Disease activity, cumulative damage and quality of life in systemic lupus erythematosus: results of a cross-sectional study. Lupus 1997; 6: 243-247.
27. Stoll T, Gordon C, Seifert B et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1608-1614.
28. Hay EM, Bacon PA, Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM 1993; 86: 447-458.
29. Fortin PR, Abrahamowicz M, Neville C et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998; 7: 101-107.
30. Partridge AJ, Karlson EW, Daltroy LH et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 1997; 40: 2199-2206.
31. Lotstein DS, Ward MM, Bush TM et al. Socioeconomic status and health in women with systemic lupus erythematosus. J Rheumatol 1998; 25: 1720-1729.